Metab Clin Exp
Ozempic face Rapidly reducing the amount of fat in your face, as can happen when taking a GLP-1, can cause changes to your appearance often referred to as Ozempic face. You might notice changes such as: Reducing your weight slowly can reduce the likelihood of these facial changes happening
Transdermal patches generally require application to areas of skin that provide consistent drug absorption whilst minimising irritation and mechanical disruption
The Phase 2 trial showed meaningful weight loss even at 1mg weekly (8.7% at 48 weeks), but the dramatic results associated with retatrutide begin at 4mg and above
10.2337/diacare.28.5.1092 30 DeYoungM
Following semaglutide, numerous anti-obesity drugs have been developed to improve the pharmacological properties of GLP-1 RAs, such as prolonging appetite suppression, increasing potency, or mitigating adverse effects, including gastrointestinal symptoms and lean mass loss [34, 35]